What is Cboe Global Mark's earnings per share (EPS)?

Cboe Global Mark (CBOE) reported diluted earnings per share of $10.42 for fiscal year 2025. This represents a 44.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cboe Global Mark Financials

CBOE

FY2025 annual

Revenue $4.7B +15.1% YoY

Net Income $1.1B +43.8% YoY

EPS (Diluted) $10.42 +44.5% YoY

Free Cash Flow $1.7B +61.7% YoY

Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Cboe Global Mark (CBOE) reported $4.7B in revenue for fiscal year 2025, up 15.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CBOE FY2025 2026-05-01

A more efficient, asset-light model is letting modest growth produce much larger profit and cash gains.

Since FY2022, cash generation changed the balance sheet more than borrowing did: cash rose by about $1.8B while long-term debt stayed near $1.4B. Because revenue increased far less over that span, the company became meaningfully more liquid mainly by converting a bigger share of sales into cash, not by taking on more leverage.

Margin expansion is coming from more than simple volume growth. Gross margin moved from 44.0% in FY2022 to 51.5% in FY2025, and operating margin widened even faster, which implies the cost structure scaled better as revenue rose and overhead absorbed a smaller share of gross profit; incremental revenue became more valuable, not just larger.

Capital intensity is low enough that operating cash is not being swallowed by reinvestment: in FY2025, operating cash flow was $1.8B against capex of $71M. Liquidity also improved, with cash at $2.2B and a current ratio of 1.9x.

Financial Health Signals

Financial health score not available

Cboe Global Mark does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Strong

8/9

Cboe Global Mark passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.59x

For every $1 of reported earnings, Cboe Global Mark generates $1.59 in operating cash flow ($1.8B OCF vs $1.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

28.05x

Cboe Global Mark earns $28.05 in operating income for every $1 of interest expense ($1.5B vs $52.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.7B

YoY+15.1%

5Y CAGR+6.6%

10Y CAGR+21.7%

Cboe Global Mark generated $4.7B in revenue in fiscal year 2025. This represents an increase of 15.1% from the prior year.

EBITDA

$1.6B

YoY+29.1%

5Y CAGR+14.1%

10Y CAGR+15.8%

Cboe Global Mark's EBITDA was $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 29.1% from the prior year.

Net Income

$1.1B

YoY+43.8%

5Y CAGR+18.6%

10Y CAGR+18.3%

Cboe Global Mark reported $1.1B in net income in fiscal year 2025. This represents an increase of 43.8% from the prior year.

EPS (Diluted)

$10.42

YoY+44.5%

5Y CAGR+19.5%

10Y CAGR+15.5%

Cboe Global Mark earned $10.42 per diluted share (EPS) in fiscal year 2025. This represents an increase of 44.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$1.7B

YoY+61.7%

5Y CAGR+3.6%

10Y CAGR+23.4%

Cboe Global Mark generated $1.7B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 61.7% from the prior year.

Cash & Debt

$2.2B

YoY+140.8%

5Y CAGR+55.3%

10Y CAGR+36.0%

Cboe Global Mark held $2.2B in cash against $1.4B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.70

YoY+14.4%

5Y CAGR+11.6%

10Y CAGR+11.9%

Cboe Global Mark paid $2.70 per share in dividends in fiscal year 2025. This represents an increase of 14.4% from the prior year.

Shares Outstanding

105M

YoY0.0%

5Y CAGR-0.5%

10Y CAGR+2.5%

Cboe Global Mark had 105M shares outstanding in fiscal year 2025. That is unchanged from the prior year.

Margins & Returns

Gross Margin

51.5%

YoY+0.9pp

5Y CAGR+14.9pp

10Y CAGR-33.1pp

Cboe Global Mark's gross margin was 51.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.9 percentage points from the prior year.

Operating Margin

31.1%

YoY+4.3pp

5Y CAGR+11.8pp

10Y CAGR-17.1pp

Cboe Global Mark's operating margin was 31.1% in fiscal year 2025, reflecting core business profitability. This is up 4.3 percentage points from the prior year.

Net Margin

23.3%

YoY+4.7pp

5Y CAGR+9.7pp

10Y CAGR-7.6pp

Cboe Global Mark's net profit margin was 23.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.7 percentage points from the prior year.

Return on Equity

21.4%

YoY+3.5pp

5Y CAGR+7.4pp

10Y CAGR-57.5pp

Cboe Global Mark's ROE was 21.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.5 percentage points from the prior year.

Capital Allocation

Share Buybacks

$66.7M

YoY-67.4%

5Y CAGR-28.2%

Cboe Global Mark spent $66.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 67.4% from the prior year.

Capital Expenditures

$71.0M

YoY+16.6%

5Y CAGR+8.4%

10Y CAGR+6.1%

Cboe Global Mark invested $71.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 16.6% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

CBOE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CBOE annual income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$5.1B	$4.7B+15.1%	$4.1B+8.5%	$3.8B-4.7%	$4.0B+13.3%	$3.5B+2.0%	$3.4B+37.3%	$2.5B-9.8%	$2.8B+24.2%	$2.2B+217.0%	$703.1M+5.9%	$663.8M+7.5%	$617.2M+7.9%	$572.0M+11.7%	$512.3M+0.8%	$508.1M
Cost of Revenue	$2.3B	$2.3B+13.0%	$2.0B+9.0%	$1.9B-16.3%	$2.2B+9.8%	$2.0B-7.1%	$2.2B+59.9%	$1.4B-12.4%	$1.6B+25.8%	$1.2B+802.3%	$136.7M+33.9%	$102.1M	N/A	N/A	N/A	N/A
Gross Profit	$2.7B	$2.4B+17.2%	$2.1B+8.1%	$1.9B+10.1%	$1.7B+18.0%	$1.5B+17.7%	$1.3B+10.3%	$1.1B-6.6%	$1.2B+22.2%	$995.6M+75.8%	$566.4M+0.8%	$561.7M	N/A	N/A	N/A	N/A
SG&A Expenses	$539.3M	$500.8M+8.3%	$462.4M+8.6%	$425.8M+17.3%	$363.0M+25.8%	$288.5M+28.3%	$224.9M+13.0%	$199.0M-13.0%	$228.8M+13.6%	$201.4M+77.9%	$113.2M+6.9%	$105.9M-13.0%	$121.7M+3.1%	$118.1M+13.3%	$104.2M-0.2%	$104.5M
Operating Income	$1.8B	$1.5B+33.6%	$1.1B+3.8%	$1.1B+116.1%	$489.6M-39.2%	$805.9M+21.7%	$662.2M+23.3%	$537.2M-10.4%	$599.4M+61.2%	$371.9M+24.7%	$298.2M-6.8%	$319.9M+1.9%	$313.8M+9.8%	$285.8M+17.1%	$244.1M+1.0%	$241.6M
Interest Expense	$53.1M	$52.3M+1.6%	$51.5M-17.5%	$62.4M+4.0%	$60.0M+25.0%	$48.0M+24.0%	$38.7M+2.4%	$37.8M-6.7%	$40.5M-4.9%	$42.6M+647.4%	$5.7M+13155.8%	$43K	$0	$0	$0-100.0%	$879K
Income Tax	$538.9M	$466.6M+46.3%	$318.9M+11.4%	$286.2M+44.6%	$197.9M-12.9%	$227.1M+18.2%	$192.2M+47.2%	$130.6M-10.5%	$146.0M+320.5%	-$66.2M-154.8%	$120.9M+1.6%	$119.0M-0.8%	$120.0M+11.4%	$107.7M+26.4%	$85.2M-15.4%	$100.7M
Net Income	$1.4B	$1.1B+43.8%	$764.9M+0.5%	$761.4M+224.0%	$235.0M-55.6%	$529.0M+13.0%	$468.2M+24.9%	$374.9M-12.1%	$426.5M+6.2%	$401.7M+115.0%	$186.8M-8.9%	$205.0M+8.1%	$189.7M+7.8%	$176.0M+11.8%	$157.4M+12.9%	$139.4M
EPS (Diluted)	—	$10.42+44.5%	$7.21+1.1%	$7.13+225.6%	$2.19-55.5%	$4.92+15.2%	$4.27+27.8%	$3.34-11.2%	$3.76+1.9%	$3.69+62.6%	$2.27-7.7%	$2.46+11.3%	$2.21+11.1%	$1.99+11.8%	$1.78+17.1%	$1.52

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$1.4B+13.4%	$1.3B+5.7%	$1.2B+5.5%	$1.1B-2.7%	$1.2B-1.8%	$1.2B+7.9%	$1.1B+4.9%	$1.1B
Cost of Revenue	$711.2M+30.8%	$543.9M+2.1%	$532.9M-0.6%	$536.2M-8.5%	$586.2M-6.9%	$629.8M+8.0%	$583.1M+11.3%	$523.7M
Gross Profit	$731.6M+0.4%	$728.9M+8.6%	$671.1M+10.8%	$605.5M+3.1%	$587.3M+3.9%	$565.2M+7.8%	$524.5M-1.4%	$532.0M
SG&A Expenses	$154.7M+21.0%	$127.9M+0.3%	$127.5M-1.3%	$129.2M+1.0%	$127.9M+10.1%	$116.2M+3.8%	$111.9M-6.0%	$119.1M
Operating Income	$476.0M-5.9%	$505.6M+25.2%	$403.8M+9.0%	$370.3M+9.2%	$339.1M-4.2%	$353.9M+18.6%	$298.5M-2.9%	$307.4M
Interest Expense	$13.2M-0.8%	$13.3M0.0%	$13.3M0.0%	$13.3M+3.1%	$12.9M+0.8%	$12.8M-0.8%	$12.9M+0.8%	$12.8M
Income Tax	$141.6M+9.1%	$129.8M-6.1%	$138.2M+6.9%	$129.3M+29.9%	$99.5M-0.1%	$99.6M+19.7%	$83.2M-8.1%	$90.5M
Net Income	$353.1M-8.5%	$385.7M+23.0%	$313.5M+4.2%	$300.8M+27.9%	$235.1M-6.2%	$250.6M+27.5%	$196.5M-10.1%	$218.5M
EPS (Diluted)	$3.35-8.5%	$3.66	N/A	$2.85+27.8%	$2.23-5.9%	$2.37	N/A	$2.07

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CBOE Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CBOE annual balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$9.3B+19.5%	$7.8B+4.0%	$7.5B+7.0%	$7.0B+2.7%	$6.8B+4.6%	$6.5B+27.4%	$5.1B-3.9%	$5.3B+1.1%	$5.3B+1004.6%	$476.7M+23.9%	$384.8M+0.2%	$383.9M-13.1%	$441.6M+30.3%	$338.9M+3.4%	$327.9M
Current Assets	$4.4B+78.3%	$2.5B+25.3%	$2.0B+27.2%	$1.6B+1.6%	$1.5B-2.3%	$1.6B+157.9%	$607.6M-11.1%	$683.7M+57.3%	$434.7M+84.9%	$235.1M+15.2%	$204.1M-16.4%	$244.1M-21.0%	$308.9M+52.2%	$202.9M+7.0%	$189.7M
Cash & Equivalents	$2.2B+140.8%	$920.3M+69.4%	$543.2M+25.5%	$432.7M+26.6%	$341.9M+39.3%	$245.4M+7.0%	$229.3M-16.6%	$275.1M+91.7%	$143.5M+47.5%	$97.3M-4.9%	$102.3M-30.8%	$147.9M-33.2%	$221.3M+63.2%	$135.6M+0.5%	$134.9M
Accounts Receivable	$391.4M-12.0%	$444.6M+31.8%	$337.3M-8.8%	$369.8M+13.1%	$326.9M-3.1%	$337.3M+43.7%	$234.7M-18.3%	$287.3M+32.2%	$217.3M+183.3%	$76.7M+22.7%	$62.5M+7.1%	$58.4M+17.0%	$49.9M+9.2%	$45.7M+21.5%	$37.6M
Goodwill	$3.2B+0.8%	$3.1B-0.5%	$3.1B+0.6%	$3.1B+3.2%	$3.0B+4.5%	$2.9B+7.9%	$2.7B-0.3%	$2.7B-0.6%	$2.7B+10116.6%	$26.5M+244.2%	$7.7M	$0	N/A	N/A	N/A
Total Liabilities	$4.2B+18.7%	$3.5B+0.2%	$3.5B-0.9%	$3.5B+10.1%	$3.2B+1.3%	$3.2B+80.2%	$1.8B-15.1%	$2.1B-3.9%	$2.2B+1374.1%	$146.2M+16.8%	$125.1M-6.5%	$133.8M-14.8%	$157.1M+57.5%	$99.7M+8.9%	$91.6M
Current Liabilities	$2.4B+69.3%	$1.4B+0.9%	$1.4B-6.3%	$1.5B+26.3%	$1.2B-11.0%	$1.3B+366.4%	$281.6M-52.7%	$595.9M+78.4%	$334.0M+271.5%	$89.9M+21.5%	$74.0M+0.5%	$73.7M-31.4%	$107.5M+106.1%	$52.1M-0.3%	$52.3M
Long-Term Debt	$1.4B+0.1%	$1.4B+0.1%	$1.4B+0.1%	$1.4B+10.6%	$1.3B+14.5%	$1.1B+30.8%	$867.6M-5.2%	$915.6M-26.0%	$1.2B	$0	N/A	N/A	N/A	N/A	N/A
Total Equity	$5.1B+20.1%	$4.3B+7.4%	$4.0B+15.0%	$3.5B-3.9%	$3.6B+7.6%	$3.3B-0.2%	$3.4B+3.5%	$3.2B+4.2%	$3.1B+878.5%	$317.9M+22.4%	$259.7M+3.9%	$250.0M-12.1%	$284.5M+19.0%	$239.1M+1.2%	$236.3M
Retained Earnings	$3.5B+25.8%	$2.8B+11.5%	$2.5B+16.3%	$2.2B+1.2%	$2.1B+18.5%	$1.8B+19.6%	$1.5B+17.4%	$1.3B+29.7%	$993.3M+39.7%	$710.8M+17.8%	$603.6M+27.9%	$472.0M+35.1%	$349.3M+26.8%	$275.5M+18.7%	$232.1M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$10.6B-4.2%	$11.1B+19.0%	$9.3B+2.6%	$9.1B+0.2%	$9.0B+4.4%	$8.7B+11.3%	$7.8B-10.6%	$8.7B
Current Assets	$5.9B-4.8%	$6.2B+40.8%	$4.4B+18.2%	$3.7B0.0%	$3.7B+11.3%	$3.4B+35.6%	$2.5B-25.3%	$3.3B
Cash & Equivalents	$2.3B+6.6%	$2.1B-3.7%	$2.2B+48.1%	$1.5B+19.1%	$1.3B+20.0%	$1.0B+13.8%	$920.3M+20.6%	$763.2M
Accounts Receivable	$570.6M+10.9%	$514.6M+31.5%	$391.4M-10.5%	$437.3M-1.6%	$444.3M-9.9%	$493.0M+10.9%	$444.6M+18.2%	$376.2M
Goodwill	$3.0B-3.0%	$3.1B-0.3%	$3.2B+0.1%	$3.1B-0.3%	$3.2B+0.8%	$3.1B+0.2%	$3.1B-0.8%	$3.2B
Total Liabilities	$5.0B-12.5%	$5.7B+36.7%	$4.2B-0.4%	$4.2B-4.6%	$4.4B+4.0%	$4.2B+20.1%	$3.5B-22.1%	$4.5B
Current Liabilities	$3.8B-15.7%	$4.5B+90.2%	$2.4B+8.4%	$2.2B-8.7%	$2.4B+13.8%	$2.1B+50.4%	$1.4B-41.6%	$2.4B
Long-Term Debt	$794.2M0.0%	$793.9M-45.0%	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B0.0%	$1.4B
Total Equity	$5.6B+4.7%	$5.4B+4.6%	$5.1B+5.2%	$4.9B+4.7%	$4.7B+4.8%	$4.5B+4.0%	$4.3B+1.7%	$4.2B
Retained Earnings	$4.1B+7.2%	$3.9B+8.7%	$3.5B+4.4%	$3.4B+7.1%	$3.2B+5.6%	$3.0B+6.5%	$2.8B-3.3%	$2.9B

Not reported in any period shown, so not listed: Inventory.

CBOE Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CBOE annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$2.0B	$1.8B+59.2%	$1.1B+2.3%	$1.1B+65.2%	$651.1M+9.1%	$596.8M-59.1%	$1.5B+130.5%	$632.8M+18.3%	$534.7M+42.8%	$374.4M+63.1%	$229.6M-6.4%	$245.3M-6.6%	$262.7M+17.1%	$224.4M+11.9%	$200.5M-1.3%	$203.1M
Capital Expenditures	$88.3M	$71.0M+16.6%	$60.9M+35.3%	$45.0M-24.7%	$59.8M+17.3%	$51.0M+7.6%	$47.4M+35.0%	$35.1M-3.3%	$36.3M-3.2%	$37.5M-15.5%	$44.4M+13.0%	$39.3M	N/A	N/A	N/A	N/A
Free Cash Flow	$1.9B	$1.7B+61.7%	$1.0B+0.9%	$1.0B+74.3%	$591.3M+8.3%	$545.8M-61.3%	$1.4B+136.1%	$597.7M+19.9%	$498.4M+47.9%	$336.9M+81.9%	$185.2M-10.1%	$206.0M	N/A	N/A	N/A	N/A
Investing Cash Flow	$462.2M	$450.2M+417.5%	-$141.8M-157.4%	-$55.1M+93.4%	-$835.1M-136.8%	-$352.7M+18.1%	-$430.5M-2607.5%	-$15.9M+37.9%	-$25.6M+98.2%	-$1.4B-1602.0%	-$84.4M-6.3%	-$79.4M	N/A	N/A	-$33.0M-8.9%	-$30.3M
Financing Cash Flow	-$405.1M	-$371.6M+24.9%	-$495.0M+24.6%	-$656.1M-903.1%	$81.7M+140.8%	-$200.3M+0.7%	-$201.7M+69.6%	-$662.9M-78.4%	-$371.6M-133.8%	$1.1B+832.2%	-$150.2M+29.0%	-$211.5M	N/A	N/A	-$166.9M-82.0%	-$91.7M
Dividends Paid	$303.0M	$284.3M+14.0%	$249.4M+11.6%	$223.5M+6.7%	$209.4M+8.3%	$193.3M+13.3%	$170.6M+13.7%	$150.0M+15.1%	$130.3M+10.3%	$118.1M+50.4%	$78.5M+6.9%	$73.4M	N/A	N/A	$47.8M+18.5%	$40.4M
Share Buybacks	$75.3M	$66.7M-67.4%	$204.8M+144.1%	$83.9M-16.8%	$100.9M+24.1%	$81.3M-76.7%	$349.1M+122.5%	$156.9M+11.4%	$140.9M	N/A	$60.5M-54.2%	$132.2M-21.5%	$168.3M+271.7%	$45.3M-9.0%	$49.7M+5.9%	$47.0M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$503.2M-125.7%	$2.0B+456.7%	$352.1M+128.8%	$153.9M-53.9%	$333.7M-63.4%	$912.9M+228.5%	-$710.4M-22.8%	-$578.5M
Capital Expenditures	$33.1M+72.4%	$19.2M-4.0%	$20.0M+25.0%	$16.0M-21.2%	$20.3M+38.1%	$14.7M-38.2%	$23.8M+98.3%	$12.0M
Free Cash Flow	-$536.3M-127.6%	$1.9B+484.4%	$332.1M+140.8%	$137.9M-56.0%	$313.4M-65.1%	$898.2M+222.3%	-$734.2M-24.3%	-$590.5M
Investing Cash Flow	-$106.9M-504.0%	-$17.7M-104.2%	$419.3M+150.3%	$167.5M+243.3%	-$116.9M-493.4%	-$19.7M+84.5%	-$126.8M-458.2%	$35.4M
Financing Cash Flow	-$111.6M+20.4%	-$140.2M-80.9%	-$77.5M-2.2%	-$75.8M+27.0%	-$103.8M+9.3%	-$114.5M-62.0%	-$70.7M+9.5%	-$78.1M
Dividends Paid	$75.7M-0.1%	$75.8M0.0%	$75.8M+0.1%	$75.7M+14.0%	$66.4M0.0%	$66.4M0.0%	$66.4M+0.2%	$66.3M
Share Buybacks	$34.4M-15.9%	$40.9M	$0	$0-100.0%	$36.7M+22.3%	$30.0M+5900.0%	$500K-98.1%	$26.4M

CBOE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CBOE annual financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	51.5%+0.9pp	50.6%-0.2pp	50.8%+6.8pp	44.0%+1.8pp	42.2%+5.6pp	36.6%-9.0pp	45.6%+1.6pp	44.0%-0.7pp	44.7%-35.9pp	80.6%-4.1pp	84.6%	N/A	N/A	N/A	N/A
Operating Margin	31.1%+4.3pp	26.8%-1.2pp	28.0%+15.7pp	12.4%-10.7pp	23.1%+3.7pp	19.3%-2.2pp	21.5%-0.1pp	21.6%+5.0pp	16.7%-25.7pp	42.4%-5.8pp	48.2%-2.6pp	50.8%+0.9pp	50.0%+2.3pp	47.6%+0.1pp	47.5%
Net Margin	23.3%+4.7pp	18.7%-1.5pp	20.2%+14.2pp	5.9%-9.2pp	15.1%+1.5pp	13.7%-1.4pp	15.0%-0.4pp	15.4%-2.6pp	18.0%-8.5pp	26.6%-4.3pp	30.9%+0.1pp	30.7%0.0pp	30.8%+0.1pp	30.7%+3.3pp	27.4%
Return on Equity	21.4%+3.5pp	17.9%-1.2pp	19.1%+12.3pp	6.8%-7.9pp	14.7%+0.7pp	14.0%+2.8pp	11.2%-2.0pp	13.2%+0.3pp	12.9%-45.9pp	58.8%-20.2pp	78.9%+3.0pp	75.9%+14.0pp	61.9%-4.0pp	65.8%+6.8pp	59.0%
Return on Assets	11.8%+2.0pp	9.8%-0.4pp	10.2%+6.8pp	3.4%-4.4pp	7.8%+0.6pp	7.2%-0.2pp	7.3%-0.7pp	8.0%+0.4pp	7.6%-31.6pp	39.2%-14.1pp	53.3%+3.9pp	49.4%+9.6pp	39.9%-6.6pp	46.5%+3.9pp	42.5%
Current Ratio	1.87+0.1x	1.78+0.3x	1.43+0.4x	1.05-0.3x	1.31+0.1x	1.19-1.0x	2.16+1.0x	1.15-0.2x	1.30-1.3x	2.62-0.1x	2.76-0.6x	3.31+0.4x	2.87-1.0x	3.89+0.3x	3.63
Debt-to-Equity	0.28-0.1x	0.340.0x	0.36-0.1x	0.41+0.1x	0.360.0x	0.34+0.1x	0.260.0x	0.28-0.1x	0.40+0.4x	0.00-0.5x	0.48-0.1x	0.540.0x	0.55+0.1x	0.420.0x	0.39
FCF Margin	35.7%+10.3pp	25.4%-1.9pp	27.3%+12.4pp	14.9%-0.7pp	15.6%-25.6pp	41.2%+17.2pp	23.9%+5.9pp	18.0%+2.9pp	15.1%-11.2pp	26.3%-4.7pp	31.0%	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	50.7%-6.6pp	57.3%+1.5pp	55.7%+2.7pp	53.0%+3.0pp	50.0%+2.7pp	47.3%-0.1pp	47.3%-3.0pp	50.4%
Operating Margin	33.0%-6.7pp	39.7%+6.2pp	33.5%+1.1pp	32.4%+3.5pp	28.9%-0.7pp	29.6%+2.7pp	27.0%-2.2pp	29.1%
Net Margin	24.5%-5.8pp	30.3%+4.3pp	26.0%-0.3pp	26.4%+6.3pp	20.0%-0.9pp	21.0%+3.2pp	17.7%-3.0pp	20.7%
Return on Equity	6.3%-0.9pp	7.2%+1.1pp	6.1%-0.1pp	6.2%+1.1pp	5.0%-0.6pp	5.6%+1.0pp	4.6%-0.6pp	5.2%
Return on Assets	3.3%-0.1pp	3.5%+0.1pp	3.4%+0.1pp	3.3%+0.7pp	2.6%-0.3pp	2.9%+0.4pp	2.5%0.0pp	2.5%
Current Ratio	1.57+0.2x	1.39-0.5x	1.87+0.2x	1.72+0.1x	1.570.0x	1.60-0.2x	1.78+0.4x	1.39
Debt-to-Equity	0.140.0x	0.15-0.1x	0.280.0x	0.300.0x	0.310.0x	0.320.0x	0.340.0x	0.34
FCF Margin	-37.2%	152.5%	27.6%+15.5pp	12.1%-14.6pp	26.7%-48.5pp	75.2%+141.5pp	-66.3%-10.4pp	-55.9%

Similar Companies

TransUnion TRU

$15.2B

Factset Resh Sys Inc FDS

$9.9B

Nasdaq Inc NDAQ

$53.5B

MSCI Inc MSCI

$40.9B

Morningstar MORN

$7.4B

Where Cboe Global Mark Ranks

Frequently Asked Questions

What is Cboe Global Mark's annual revenue?

Cboe Global Mark (CBOE) reported $4.7B in total revenue for fiscal year 2025. This represents a 15.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cboe Global Mark's revenue growing?

Cboe Global Mark (CBOE) revenue grew by 15.1% year-over-year, from $4.1B to $4.7B in fiscal year 2025.

Is Cboe Global Mark profitable?

Yes, Cboe Global Mark (CBOE) reported a net income of $1.1B in fiscal year 2025, with a net profit margin of 23.3%.

What is Cboe Global Mark's EBITDA?

Cboe Global Mark (CBOE) had EBITDA of $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cboe Global Mark have?

As of fiscal year 2025, Cboe Global Mark (CBOE) had $2.2B in cash and equivalents against $1.4B in long-term debt.

What is Cboe Global Mark's gross margin?

Cboe Global Mark (CBOE) had a gross margin of 51.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cboe Global Mark's operating margin?

Cboe Global Mark (CBOE) had an operating margin of 31.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cboe Global Mark's net profit margin?

Cboe Global Mark (CBOE) had a net profit margin of 23.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Cboe Global Mark pay dividends?

Yes, Cboe Global Mark (CBOE) paid $2.70 per share in dividends during fiscal year 2025.

What is Cboe Global Mark's return on equity (ROE)?

Cboe Global Mark (CBOE) has a return on equity of 21.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cboe Global Mark's free cash flow?

Cboe Global Mark (CBOE) generated $1.7B in free cash flow during fiscal year 2025. This represents a 61.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cboe Global Mark's operating cash flow?

Cboe Global Mark (CBOE) generated $1.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cboe Global Mark's total assets?

Cboe Global Mark (CBOE) had $9.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cboe Global Mark's capital expenditures?

Cboe Global Mark (CBOE) invested $71.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Cboe Global Mark buy back shares?

Yes, Cboe Global Mark (CBOE) spent $66.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Cboe Global Mark have outstanding?

Cboe Global Mark (CBOE) had 105M shares outstanding as of fiscal year 2025.

What is Cboe Global Mark's current ratio?

Cboe Global Mark (CBOE) had a current ratio of 1.87 as of fiscal year 2025, which is generally considered healthy.

What is Cboe Global Mark's debt-to-equity ratio?

Cboe Global Mark (CBOE) had a debt-to-equity ratio of 0.28 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cboe Global Mark's return on assets (ROA)?

Cboe Global Mark (CBOE) had a return on assets of 11.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cboe Global Mark's Piotroski F-Score?

Cboe Global Mark (CBOE) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cboe Global Mark's earnings high quality?

Cboe Global Mark (CBOE) has an earnings quality ratio of 1.59x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cboe Global Mark cover its interest payments?

Cboe Global Mark (CBOE) has an interest coverage ratio of 28.05x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.